{"disease":{"id":"gastroesophageal-cancer-gc","name":"gastroesophageal cancer gc"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07277413","title":"A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":260,"lead_sponsor_name":"IDEAYA Biosciences","has_results":false},{"nct_id":"NCT06629714","title":"Impact of Pretreatment Emotional Distress on Survival and the Predictive Role of Peripheral Biomarkers in Immunotherapy Response Among Gastroesophageal and Lung Cancer Patients","phase":"","overall_status":"COMPLETED","enrollment_count":196,"lead_sponsor_name":"Anhui Medical University","has_results":false},{"nct_id":"NCT03314935","title":"A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid Tumors","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":149,"lead_sponsor_name":"Incyte Corporation","has_results":true},{"nct_id":"NCT06687291","title":"Cognitive Impact Associated With Surgery For Gastric Or Esophageal Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":130,"lead_sponsor_name":"Karolinska Institutet","has_results":false},{"nct_id":"NCT06922279","title":"First Line gastroeSOphageal metastatiC canceR primAry and disTant (if Oligometastatic) lEsions-directed Radiotherapy, a Multicentric, Phase III, Randomized Controlled Trial","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":108,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT07419841","title":"A Phase 1 Study of the Safety and Tolerability of CTX-10726","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":70,"lead_sponsor_name":"Compass Therapeutics","has_results":false},{"nct_id":"NCT05632939","title":"ASKB589 in Combination With CAPOX and PD-1 Inhibitors in Patients With Advanced, and Unresectable G/GEJ Cancer.","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":62,"lead_sponsor_name":"AskGene Pharma, Inc.","has_results":false}],"total":7},"guidelines":[],"source":"Drug Landscape verified database"}